News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
750,576 Results
Type
Article (53797)
Company Profile (354)
Press Release (696424)
Multimedia
Podcasts (104)
Webinars (15)
Section
Business (214157)
Career Advice (2146)
Deals (37109)
Drug Delivery (114)
Drug Development (86312)
Employer Resources (176)
FDA (17085)
Job Trends (15698)
News (364294)
Policy (35089)
Tag
Academia (2794)
Academic (1)
Accelerated approval (12)
Adcomms (29)
Allergies (101)
Alliances (52903)
ALS (114)
Alzheimer's disease (1491)
Antibody-drug conjugate (ADC) (183)
Approvals (17065)
Artificial intelligence (344)
Autoimmune disease (31)
Automation (19)
Bankruptcy (377)
Best Places to Work (11977)
BIOSECURE Act (20)
Biosimilars (132)
Biotechnology (236)
Bladder cancer (100)
Brain cancer (39)
Breast cancer (392)
Cancer (3083)
Cardiovascular disease (230)
Career advice (1804)
Career pathing (31)
CAR-T (199)
CDC (36)
Cell therapy (532)
Cervical cancer (24)
Clinical research (70758)
Collaboration (1074)
Company closure (3)
Compensation (701)
Complete response letters (31)
COVID-19 (2792)
CRISPR (66)
C-suite (344)
Cystic fibrosis (118)
Data (3066)
Decentralized trials (2)
Denatured (32)
Depression (65)
Diabetes (360)
Diagnostics (6736)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (148)
Drug pricing (139)
Drug shortages (31)
Duchenne muscular dystrophy (132)
Earnings (89968)
Editorial (44)
Employer branding (21)
Employer resources (152)
Events (119753)
Executive appointments (878)
FDA (18790)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (970)
Gene editing (142)
Generative AI (25)
Gene therapy (402)
GLP-1 (850)
Government (4826)
Grass and pollen (5)
Guidances (182)
Healthcare (19663)
HIV (44)
Huntington's disease (31)
IgA nephropathy (41)
Immunology and inflammation (167)
Immuno-oncology (10)
Indications (40)
Infectious disease (2979)
Inflammatory bowel disease (156)
Inflation Reduction Act (11)
Influenza (64)
Intellectual property (123)
Interviews (332)
IPO (17078)
IRA (51)
Job creations (4123)
Job search strategy (1529)
Kidney cancer (14)
Labor market (53)
Layoffs (546)
Leadership (21)
Legal (8642)
Liver cancer (85)
Longevity (12)
Lung cancer (435)
Lymphoma (214)
Machine learning (11)
Management (60)
Manufacturing (416)
MASH (94)
Medical device (13754)
Medtech (13759)
Mergers & acquisitions (20753)
Metabolic disorders (895)
Multiple sclerosis (99)
NASH (17)
Neurodegenerative disease (123)
Neuropsychiatric disorders (34)
Neuroscience (2199)
NextGen: Class of 2025 (6877)
Non-profit (4765)
Now hiring (48)
Obesity (451)
Opinion (257)
Ovarian cancer (104)
Pain (121)
Pancreatic cancer (126)
Parkinson's disease (189)
Partnered (22)
Patents (315)
Patient recruitment (174)
Peanut (53)
People (60731)
Pharmaceutical (96)
Pharmacy benefit managers (23)
Phase I (21975)
Phase II (30967)
Phase III (23249)
Pipeline (1679)
Policy (221)
Postmarket research (2968)
Preclinical (9559)
Press Release (68)
Prostate cancer (150)
Psychedelics (42)
Radiopharmaceuticals (273)
Rare diseases (491)
Real estate (6386)
Recruiting (68)
Regulatory (24255)
Reports (50)
Research institute (2524)
Resumes & cover letters (365)
Rett syndrome (9)
RNA editing (10)
RSV (55)
Schizophrenia (96)
Series A (164)
Series B (111)
Service/supplier (12)
Sickle cell disease (66)
Special edition (21)
Spinal muscular atrophy (152)
Sponsored (35)
Startups (3858)
State (2)
Stomach cancer (17)
Supply chain (78)
Tariffs (64)
The Weekly (70)
Vaccines (874)
Venture capital (54)
Weight loss (287)
Women's health (47)
Worklife (16)
Date
Today (77)
Last 7 days (356)
Last 30 days (1908)
Last 365 days (32252)
2025 (17493)
2024 (36455)
2023 (41352)
2022 (52669)
2021 (57248)
2020 (55778)
2019 (48591)
2018 (36788)
2017 (34133)
2016 (33843)
2015 (39745)
2014 (33706)
2013 (29119)
2012 (31264)
2011 (31925)
2010 (30263)
Location
Africa (844)
Alabama (61)
Alaska (7)
Arizona (257)
Arkansas (14)
Asia (43132)
Australia (7085)
California (7588)
Canada (2396)
China (711)
Colorado (327)
Connecticut (326)
Delaware (196)
Europe (94141)
Florida (1134)
Georgia (250)
Hawaii (1)
Idaho (60)
Illinois (666)
India (28)
Indiana (372)
Iowa (17)
Japan (236)
Kansas (112)
Kentucky (30)
Louisiana (14)
Maine (64)
Maryland (1061)
Massachusetts (5691)
Michigan (249)
Minnesota (464)
Mississippi (3)
Missouri (93)
Montana (31)
Nebraska (25)
Nevada (81)
New Hampshire (66)
New Jersey (2127)
New Mexico (30)
New York (2137)
North Carolina (1130)
North Dakota (8)
Northern California (3322)
Ohio (239)
Oklahoma (16)
Oregon (42)
Pennsylvania (1641)
Puerto Rico (18)
Rhode Island (36)
South America (1217)
South Carolina (36)
South Dakota (1)
Southern California (2834)
Tennessee (128)
Texas (1147)
United States (28298)
Utah (226)
Virginia (199)
Washington D.C. (72)
Washington State (659)
West Virginia (4)
Wisconsin (79)
750,576 Results for "cancer prevention pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bexion Pharmaceuticals, Inc. Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2025
April 25, 2025
·
2 min read
Press Releases
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment
July 9, 2025
·
3 min read
Approvals
Moderna, Merck, UroGen, Score RSV and Cancer Nods in June
The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an approval in bladder cancer, and more key regulatory nods from the past month.
June 30, 2025
·
9 min read
·
Tristan Manalac
Press Releases
Tonix Pharmaceuticals Announces Peer-Reviewed Publication in Cancer Cell Journal Highlighting Positive Preclinical Data of mTNX-1700 in Gastric Cancer Animal Models
July 3, 2025
·
12 min read
Press Releases
Syantra Inc completes new IP filings in cancer screening and treatment
May 22, 2025
·
2 min read
BioMidwest
Calviri Announces Completion of Groundbreaking Preventative Canine Cancer Vaccine Trial
Calviri, Inc. announced the successful conclusion of the Vaccine Against Canine Cancer Study on May 4, 2024; a five-year clinical trial investigating a novel preventative cancer vaccine in dogs.
June 3, 2024
·
4 min read
Press Releases
Synfini Inc. and O2nix Bio Announce Strategic Collaboration to Develop Novel Cancer Therapeutics Targeting FTSJ1
June 18, 2025
·
3 min read
Press Releases
CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER
July 8, 2025
·
7 min read
Press Releases
Allosteric Bioscience, Inc. Licenses Sarcopenia (Muscle Loss) Prevention/Treatment Technology from Johns Hopkins University
March 7, 2025
·
4 min read
Press Releases
Perre Fabre Pharmaceuticals, Inc. Announces Transfer of Investigational New Drug Application for Tabelecleucel from Atara Biotherapeutics, Inc.
July 16, 2025
·
5 min read
1 of 75,058
Next
